80 related articles for article (PubMed ID: 32181815)
1. Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.
Eskelund CW; Husby S; Favero F; Klausen TW; Rodriguez-Gonzalez FG; Kolstad A; Pedersen LB; Räty RK; Geisler CH; Jerkeman M; Weischenfeldt J; Grønbæk K
Blood; 2020 May; 135(22):2000-2004. PubMed ID: 32181815
[No Abstract] [Full Text] [Related]
2. Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.
Husby S; Bæch-Laursen C; Eskelund CW; Favero F; Jespersen JS; Hutchings M; Pedersen LB; Niemann CU; Weischenfeldt J; Räty R; Larsen TS; Kolstad A; Jerkeman M; Grønbæk K
Leukemia; 2022 Dec; 36(12):2912-2916. PubMed ID: 36274067
[No Abstract] [Full Text] [Related]
3. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Clonal Evolution Goes Spatial.
Austin R; Aifantis I
Blood Cancer Discov; 2024 May; 5(3):139-141. PubMed ID: 38651690
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19.
Miller PG; Fell GG; Foy BH; Scherer AK; Gibson CJ; Sperling AS; Burugula BB; Nakao T; Uddin MM; Warren H; Bry L; Pozdnyakova O; Frigault MJ; Bick AG; Neuberg D; Higgins JM; Mansour MK; Natarajan P; Kim AS; Kitzman JO; Ebert BL
Blood; 2022 Nov; 140(18):1993-1997. PubMed ID: 36096050
[TBL] [Abstract][Full Text] [Related]
6. Evolution of clonal hematopoiesis.
van Zeventer IA; de Graaf AO; Jansen JH; Huls G
Clin Transl Med; 2023 Oct; 13(10):e1444. PubMed ID: 37846136
[No Abstract] [Full Text] [Related]
7. Clearing the way for new therapies in clonal hematopoiesis.
Ling VY; Lane SW
Blood Adv; 2023 Nov; 7(22):7151-7152. PubMed ID: 38015494
[No Abstract] [Full Text] [Related]
8. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
Gao T; Ptashkin R; Bolton KL; Sirenko M; Fong C; Spitzer B; Menghrajani K; Ossa JEA; Zhou Y; Bernard E; Levine M; Martinez JSM; Zhang Y; Franch-Expósito S; Patel M; Braunstein LZ; Kelly D; Yabe M; Benayed R; Caltabellotta NM; Philip J; Paraiso E; Mantha S; Solit DB; Diaz LA; Berger MF; Klimek V; Levine RL; Zehir A; Devlin SM; Papaemmanuil E
Nat Commun; 2021 Jan; 12(1):338. PubMed ID: 33436578
[TBL] [Abstract][Full Text] [Related]
9. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
[TBL] [Abstract][Full Text] [Related]
10. Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.
Nowakowski GS; Hong F; Scott DW; Macon WR; King RL; Habermann TM; Wagner-Johnston N; Casulo C; Wade JL; Nagargoje GG; Reynolds CM; Cohen JB; Khan N; Amengual JE; Richards KL; Little RF; Leonard JP; Friedberg JW; Kostakoglu L; Kahl BS; Witzig TE
J Clin Oncol; 2021 Apr; 39(12):1329-1338. PubMed ID: 33555941
[TBL] [Abstract][Full Text] [Related]
11. A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Morschhauser F; Feugier P; Flinn IW; Gasiorowski R; Greil R; Illés Á; Johnson NA; Larouche JF; Lugtenburg PJ; Patti C; Salles GA; Trněný M; de Vos S; Mir F; Samineni D; Kim SY; Jiang Y; Punnoose E; Sinha A; Clark E; Spielewoy N; Humphrey K; Bazeos A; Zelenetz AD
Blood; 2021 Feb; 137(5):600-609. PubMed ID: 33538797
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation analysis along the progression of gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type.
Dugge R; Wagener R; Mӧller P; Barth TFE
Br J Haematol; 2021 Apr; 193(2):369-374. PubMed ID: 33590882
[TBL] [Abstract][Full Text] [Related]
13. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.
Rapaport F; Neelamraju Y; Baslan T; Hassane D; Gruszczynska A; Robert de Massy M; Farnoud N; Haddox S; Lee T; Medina-Martinez J; Sheridan C; Thurmond A; Becker M; Bekiranov S; Carroll M; Moses Murdock H; Valk PJM; Bullinger L; D'Andrea R; Lowe SW; Neuberg D; Levine RL; Melnick A; Garrett-Bakelman FE
Leukemia; 2021 Sep; 35(9):2688-2692. PubMed ID: 33580203
[No Abstract] [Full Text] [Related]
14. Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Dobson R; Du PY; Rásó-Barnett L; Yao WQ; Chen Z; Casa C; Ei-Daly H; Farkas L; Soilleux E; Wright P; Grant JW; Rodriguez-Justo M; Follows GA; Rashed H; Fabre M; Baxter EJ; Vassiliou G; Wotherspoon A; Attygalle AD; Liu H; Du MQ
Haematologica; 2022 Feb; 107(2):489-499. PubMed ID: 33567811
[TBL] [Abstract][Full Text] [Related]
15. Be mindful of the central nervous system in Burkitt lymphoma.
Roschewski M
Haematologica; 2021 Jul; 106(7):1785-1786. PubMed ID: 33538157
[No Abstract] [Full Text] [Related]
16. Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Zayac AS; Evens AM; Danilov A; Smith SD; Jagadeesh D; Leslie LA; Wei C; Kim SH; Naik S; Sundaram S; Reddy N; Farooq U; Kenkre VP; Epperla N; Blum KA; Khan N; Singh D; Alderuccio JP; Godara A; Yazdy MS; Diefenbach C; Rabinovich E; Varma G; Karmali R; Shao Y; Trabolsi A; Burkart M; Martin P; Stettner S; Chauhan A; Choi YK; Straker-Edwards A; Klein A; Churnetski MC; Boughan KM; Berg S; Haverkos BM; Orellana-Noia VM; D'Angelo C; Bond DA; Maliske SM; Vaca R; Magarelli G; Sperling A; Gordon MJ; David KA; Savani M; Caimi P; Kamdar M; Lunning MA; Palmisiano N; Venugopal P; Portell CA; Bachanova V; Phillips T; Lossos IS; Olszewski AJ
Haematologica; 2021 Jul; 106(7):1932-1942. PubMed ID: 33538152
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom.
Roschewski M
Haematologica; 2021 Feb; 106(2):332-334. PubMed ID: 33522784
[No Abstract] [Full Text] [Related]
18. Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis.
Strati P; Cheng PTM; Steiner RE; Alcedo Andrade PE; Feng L; Sano D; Rao VA; Singh P; Miranda R; Gunther JR; Pinnix CC; Dabaja BS; Cuglievan B; Xing K; Villa D; Skinnider B; Sehn LH; Connors JM; Nieto Y; Ahmed S; Lee HJ; Savage KJ
Br J Haematol; 2021 Feb; 192(3):560-567. PubMed ID: 33517581
[TBL] [Abstract][Full Text] [Related]
19. ΔSUVmax for interim PET in DLBCL: old is new.
Meignan M; Gallamini A
Blood; 2020 Jun; 135(25):2202-2203. PubMed ID: 32556130
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
